Table 2 Comparison of procedure-related outcomes between the three groups.
Franseen n = 196 | Menghini-tip n = 113 | Reverse-bevel n = 360 | P value | |
|---|---|---|---|---|
Approaches, n (%) | 0.004 | |||
Trans-duodenal | 96 (49.0%) | 60 (53.1%) | 227 (63.1%) | |
Trans-gastric | 100 (51.0%) | 53 (46.9%) | 133 (36.9%) | |
Number of passes, mean ± SD | 2.8 ± 1.0 | 2.9 ± 0.5 | 3.4 ± 1.3 | < 0.001 |
Application of suction, n (%) | 196 (100.0%) | 113 (100.0%) | 360 (100.0%) | |
Amounts of suction, n (%) | < 0.001 | |||
10 ml | 0 (0.0%) | 0 (0.0%) | 235 (65.3%) | |
20 ml | 196 (100.0%) | 113 (100.0%) | 125 (34.7%) | |
Application of stylet, n (%) | 145 (74.0%) | 113 (100.0%) | 275 (76.4%) | < 0.001 |
Fanning technique, n (%) | 196 (100.0%) | 60 (53.1%) | 296 (82.2%) | < 0.001 |
Technical success, n (%) | 196 (100.0%) | 113 (100.0%) | 360 (100.0%) | |
Adverse events, n (%) | ||||
Immediate bleeding | 1 (0.5%) | 2 (1.8%) | 5 (1.4%) | 0.546 |
Delayed bleeding | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
Pancreatitis | 3 (1.5%) | 0 (0.0%) | 2 (0.6%) | 0.266 |
Infection | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
Any cardiopulmonary distress. during procedure | 1 (0.5%) | 1 (0.9%) | 0 (0.0%) | 0.263 |
Final diagnosis, n (%) | 0.010 | |||
Inflammatory tumor | 17 (8.7%) | 19 (16.8%) | 29 (8.1%) | |
Benign tumor | 18 (9.2%) | 19 (16.8%) | 32 (8.9%) | |
PNEC | 1 (0.5%) | 2 (1.8%) | 1 (0.3%) | |
Lymphoma | 0 (0.0%) | 1 (0.9%) | 3 (0.8%) | |
Metastatic carcinoma | 0 (0.0%) | 1 (0.9%) | 3 (0.8%) | |
Ductal adenocarcinoma | 160 (81.6%) | 71 (62.8%) | 292 (81.1%) | |
Presence of histologic core, n (%) | 192 (98.0%) | 97 (85.8%) | 331 (91.9%) | < 0.001 |
Possibility for IHC stain, n (%) | 187 (95.4%) | 74 (65.5%) | 318 (88.3%) | < 0.001 |
